Home › Sunshine Biopharma Announces That Its Breast Cancer Drug Candidate, Adva-27a, Also Destroys Pancreatic Cancer Cells
 

Keywords :   


Sunshine Biopharma Announces That Its Breast Cancer Drug Candidate, Adva-27a, Also Destroys Pancreatic Cancer Cells

2013-06-05 07:10:25| drugdiscoveryonline News Articles

Sunshine Biopharma Inc. (OTCQB: SBFM), a pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of various forms of cancer, today announced that it has completed a new IND-Enabling study in which Adva-27a, the Company's flagship oncology drug candidate for breast cancer was found to be effective at killing Pancreatic Cancer Cells in vitro

Tags: drug cells cancer candidate

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
28.06Diversified Labeling Solutions expands RFID capabilities
28.06Eastern North Pacific Tropical Weather Outlook
28.06Atlantic Tropical Weather Outlook
28.06Commitment leads to success in cattle marketing
28.06Kurz opens new facility in Germany
28.06Apex invests in Schepers laser engraving technology
28.06All4Labels opens first factory in Northeast Brazil
28.06WOW Conference Attracts Industry Leaders to Minneapolis
More »